======= SDR16C5 ======= == Gene Information == * **Official Symbol**: SDR16C5 * **Official Name**: short chain dehydrogenase/reductase family 16C member 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=195814|195814]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q8N3Y7|Q8N3Y7]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SDR16C5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SDR16C5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/608989|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Oxidoreductase with strong preference for NAD. Active in both the oxidative and reductive directions. Oxidizes all-trans- retinol in all-trans-retinaldehyde. No activity was detected with 11-cis-retinol or 11-cis-retinaldehyde as substrates with either NAD(+)/NADH or NADP(+)/NADPH. {ECO:0000269|PubMed:18926804}. |adh short| |KR| |keratinocyte proliferation| |retinal metabolic process| |negative regulation of histone acetylation| |positive regulation of histone deacetylation| |negative regulation of peptidyl-lysine acetylation| |negative regulation of protein acetylation| |retinol dehydrogenase activity| |positive regulation of protein deacetylation| |regulation of histone deacetylation| |activating transcription factor binding| |retinol metabolic process| |negative regulation of histone modification| |regulation of protein deacetylation| |cellular aldehyde metabolic process| |transcriptional repressor complex| |regulation of histone acetylation| |negative regulation of chromatin organization| |regulation of peptidyl-lysine acetylation| |regulation of protein acetylation| |primary alcohol metabolic process| |lipid droplet| |epithelial cell proliferation| |positive regulation of histone modification| |positive regulation of chromatin organization| |retinoid metabolic process| |diterpenoid metabolic process| |chromatin| |terpenoid metabolic process| |cellular hormone metabolic process| |negative regulation of chromosome organization| |isoprenoid metabolic process| |regulation of histone modification| |positive regulation of chromosome organization| |regulation of chromatin organization| |hormone metabolic process| |transcription corepressor activity| |alcohol metabolic process| |transcription factor binding| |regulation of chromosome organization| |negative regulation of organelle organization| |organic hydroxy compound metabolic process| |regulation of hormone levels| |cell population proliferation| |negative regulation of protein modification process| |positive regulation of organelle organization| |negative regulation of cellular component organization| |negative regulation of transcription by RNA polymerase II| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |oxidation-reduction process| |endoplasmic reticulum| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of transcription, DNA-templated| |positive regulation of cellular component organization| |lipid metabolic process| |positive regulation of protein modification process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |regulation of organelle organization| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |positive regulation of cellular protein metabolic process| |positive regulation of protein metabolic process| |negative regulation of gene expression| |small molecule metabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp494|Isoniazid 100μM R08 exp494]]|1.82| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.502| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 7989 * **Expression level (log2 read counts)**: -2.9 {{:chemogenomics:nalm6 dist.png?nolink |}}